Fig. 1
a. Clinical photographs of patient 4. b. PET imaging showing the site of progression of patient 4 before and after switching therapy to Nivolumab/Pembrolizumab. c. Clinical photographs of patient 6
Fig. 1 | Journal for ImmunoTherapy of Cancer